SBLK-200802

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameSBLK-200802

Drug Alias Nameindoleamine dioxygenase inhibitor (Bioalvo)IDO inhibitor (Bioalvo)SBLK-200802

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitors

TargetsIndoleamine 2,3-dioxygenase

Therapy Area/IndicationsAnxiety Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryPortugal

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBioalvo SA

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBioalvo SA

Active IndicationsN/A

Inactive IndicationsAnxiety Disorders

ATC CodeN/A